Currently out of the existing stock ratings of Navin Jacob, 19 are a HOLD (46.34%), 22 are a BUY (53.66%).

Navin Jacob

Work Performance Price Targets & Ratings Chart

Analyst Navin Jacob works with a stock forecast success ratio of 70.04% fulfilled within 253.42 days on average.

Navin Jacob’s has documented 120 price targets and ratings displayed on 12 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ABBV, AbbVie at 17-Jan-2024.

Wall Street Analyst Navin Jacob

Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 11/29/2021. The price target of $267 was fulfilled within 16 days with a profit of $18.47 (7.43%) receiving and performance score of 4.64.

Average potential price target upside

ABBV AbbVie LLY Eli Lilly and Company RPRX Royalty Pharma Plc AGN Allergan plc ICPT Intercept Pharmaceuticals MYL Viatris TEVA Teva Pharma Industries Ltd ADR ZTS Zoetis MRK Merck mpany CELG Celgene REGN Regeneron Pharmaceuticals VRTX Vertex Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

195

$25.2 (14.84%)

185

20 days ago

10/12 (83.33%)

$14.65 (8.12%)

191

Buy

189

$19.2 (11.31%)

181

2 months 10 days ago

9/11 (81.82%)

$15.71 (9.07%)

252

Buy

195

$25.2 (14.84%)

180

2 months 10 days ago

9/10 (90%)

$21.71 (12.53%)

445

Hold

165

$-4.8 (-2.83%)

157

2 months 30 days ago

11/11 (100%)

$2.96 (1.83%)

314

Buy

180

$10.2 (6.01%)

195

3 months 13 days ago

3/5 (60%)

$21.06 (13.25%)

496

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Navin Jacob is most bullish on?

Potential upside of $-4.8 has been obtained for ABBV (ABBVIE)

What Year was the first public recommendation made by Navin Jacob?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?